Nastech Pharmaceutical Company Inc. to Present at the Invest Northwest CEO & Investor Forum
March 13 2008 - 8:00AM
Business Wire
Nastech Pharmaceutical Company Inc. (Nasdaq: NSTK) announced today
that it will present at the Invest Northwest CEO & Investor
Forum on Tuesday, March 18, 2008, at 4:30 p.m. Pacific Time at the
Bell Harbor International Conference Center in Seattle, Washington.
To access the live audio webcast for this conference, please log on
to Nastech�s Web site at http://www.nastech.com approximately 15
minutes prior to the presentation in order to register and download
any necessary software. A replay of the audio presentation will be
available following the event. About Nastech Nastech is a clinical
stage biopharmaceutical company focusing on the development and
commercialization of innovative therapeutic products based on its
proprietary molecular biology-based drug delivery technologies and,
through its wholly-owned subsidiary, MDRNA, Inc., based on its
proprietary ribonucleic acid interference (RNAi) technology.
Nastech and its collaboration partners are developing products for
multiple therapeutic areas including osteoporosis, obesity,
diabetes, autism, respiratory diseases and inflammatory conditions.
Additional information about Nastech is available at
http://www.nastech.com.
Nastech Pharmaceutical Company (MM) (NASDAQ:NSTK)
Historical Stock Chart
From Apr 2024 to May 2024
Nastech Pharmaceutical Company (MM) (NASDAQ:NSTK)
Historical Stock Chart
From May 2023 to May 2024